Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Aquestive Therapeutics, Inc. (AQST) had Current Liabilities of $47.61M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$44.55M |
|
$-83.78M |
|
$18.55M |
|
$25.99M |
|
$115.60M |
|
$-71.05M |
|
$-12.73M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-83.78M |
|
$-71.05M |
|
$-59.51M |
|
106.93M |
|
106.93M |
|
$-0.78 |
|
$-0.78 |
|
| Balance Sheet Financials | |
$149.27M |
|
$3.89M |
|
$11.16M |
|
$160.43M |
|
|
Current Liabilities |
$47.61M |
$27.52M |
|
$146.48M |
|
$194.09M |
|
$-33.66M |
|
$-33.66M |
|
$-33.66M |
|
122.04M |
|
| Cash Flow Statement Financials | |
$-52.43M |
|
$-0.56M |
|
$102.62M |
|
$71.55M |
|
$121.17M |
|
$49.62M |
|
$7.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.14 |
|
-- |
|
-- |
|
-4.48 |
|
-0.82 |
|
58.35% |
|
-159.50% |
|
-159.50% |
|
-133.59% |
|
-188.09% |
|
-188.09% |
|
$-52.99M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
3.01 |
|
2.51 |
|
145.55 |
|
248.90% |
|
248.90% |
|
-52.23% |
|
1363.89% |
|
$-0.28 |
|
$-0.50 |
|
$-0.49 |
|